Keene & Associates’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $354K | Buy |
29,230
+6,285
| +27% | +$76.1K | 0.28% | 65 |
|
|
2024
Q3 | $337K | Buy |
22,945
+1,240
| +6% | +$18.2K | 0.26% | 69 |
|
|
2024
Q2 | $313K | Sell |
21,705
-2,110
| -9% | -$30.4K | 0.26% | 64 |
|
|
2024
Q1 | $388K | Sell |
23,815
-28,189
| -54% | -$459K | 0.29% | 62 |
|
|
2023
Q4 | $775K | Sell |
52,004
-90
| -0.2% | -$1.34K | 0.64% | 36 |
|
|
2023
Q3 | $586K | Buy |
52,094
+2,180
| +4% | +$24.5K | 0.47% | 41 |
|
|
2023
Q2 | $502K | Buy |
49,914
+322
| +0.6% | +$3.24K | 0.39% | 44 |
|
|
2023
Q1 | $466K | Buy |
49,592
+38,393
| +343% | +$361K | 0.36% | 42 |
|
|
2022
Q4 | $137K | Sell |
11,199
-16,625
| -60% | -$203K | 0.12% | 72 |
|
|
2022
Q3 | $345K | Buy |
27,824
+2,255
| +9% | +$28K | 0.32% | 43 |
|
|
2022
Q2 | $502K | Buy |
25,569
+1,529
| +6% | +$30K | 0.47% | 38 |
|
|
2022
Q1 | $627K | Buy |
24,040
+3,395
| +16% | +$88.5K | 0.51% | 42 |
|
|
2021
Q4 | $586K | Buy |
+20,645
| New | +$586K | 0.51% | 41 |
|